Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer

Clinical Trial ID NCT02532114

PubWeight™ 4.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02532114

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Persistent androgen receptor addiction in castration-resistant prostate cancer. J Hematol Oncol 2015 0.84
2 Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting. Prostate Cancer Prostatic Dis 2016 0.83
3 Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer. Clin Med Insights Oncol 2016 0.83
4 Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer. Int J Biol Sci 2016 0.81
5 Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer. Curr Urol Rep 2016 0.77
Next 100